Drug shortage
Voxelotor Tablet · Pfizer Inc.
FDA drug shortage · To Be Discontinued · updated Sep 27, 2024
Key facts
| Generic name | Voxelotor Tablet |
|---|---|
| Proprietary name | Oxbryta |
| Company | Pfizer Inc. |
| Presentation | Oxbryta, Tablet, 500 mg (NDC 72786-101-01) |
| Dosage form | Tablet |
| Strength | 500 mg |
| Status | To Be Discontinued |
| Therapeutic category | Hematology |
| Package NDCs | 72786-101-01 |
| First posted | Sep 27, 2024 |
| Last updated | Sep 27, 2024 |
| Discontinued | Sep 27, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: